Filing Details
- Accession Number:
- 0000919574-14-001983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-26 18:02:38
- Reporting Period:
- 2014-02-24
- Filing Date:
- 2014-02-26
- Accepted Time:
- 2014-02-26 18:02:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278386 | Broadwood Partners Lp | C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019 | Yes | No | No | No | |
| 1278387 | Broadwood Capital Inc | 724 Fifth Avenue 9Th Floor New York NY 10019 | Yes | No | No | No | |
| 1278388 | C Neal Bradsher | C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-02-24 | 71,000 | $79.50 | 2,264,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-24 | 0 | $0.00 | 2,264,260 | No | 4 | S | Indirect | Footnote |
| Common Stock | Disposition | 2014-02-25 | 12,600 | $80.08 | 2,251,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-25 | 0 | $0.00 | 2,251,660 | No | 4 | S | Indirect | Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Footnote |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,183 | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Broadwood Partners, L.P. on November 13, 2013. Broadwood Partners, L.P. is a reporting person.
- This constitutes the weighted average sale price. The prices range from $79.00 to $80.105. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- This constitutes the weighted average sale price. The prices range from $80.00 to $80.25. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- These securities are owned by Broadwood Partners, L.P.
- The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Broadwood Capital, Inc. and Neal C. Bradsher are each a reporting person. Each of Broadwood Capital, Inc. and Neal C. Bradsher disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- These securities are owned by Neal C. Bradsher.
Billionaire Hedge Funds
